Piton therapeutics. Piton Therapeutics is estimated to generate $4.



Piton therapeutics. Piton Therapeutics, which also operates under the name Precidiag, is located in Watertown, Massachusetts. Piton Therapeutics is estimated to generate $4. This organization primarily operates in the Microbiology and Virology Diagnostic Products business / industry within the Chemicals and Allied Products sector. Piton Therapeutics is creating first-in-class therapeutics for chronic conditions currently with limited treatment options. We design highly selective, mechanism-based treatments targeting complex neurological, metabolic, and immune diseases. United by a shared commitment to transforming patient care through precision About Precidiag Piton Therapeutics is a biotechnology company focused on precision medicine and drug discovery within the healthcare sector. Piton Therapeutics addresses medical needs in areas such as Ulcerative Colitis, Autism Spectrum At Piton Therapeutics, our Board of Directors brings together a distinguished group of leaders with deep expertise across biotechnology, drug development, venture capital, and company building. Our proprietary discovery platform utilizes advanced metagenomics, metabolic pathway analysis, and machine learning to discern the pathogenic role of gut microbiota in human health. Piton (“Pee-ton”) is pioneering the development of life-changing, first-in-class therapeutics for chronic conditions with limited therapeutic options. Piton Therapeutics is a development-stage biopharmaceutical company revolutionizing precision medicine by engineering microbiome-inspired small molecule therapies. This organization has been operating for approximately 10 years. The company employs a proprietary platform Information on valuation, funding, cap tables, investors, and executives for Piton Therapeutics. Pioneering the development of first-in-class precision therapeutics for chronic conditions | Piton (“Pee-ton”) is pioneering the development of life-changing, first-in-class therapeutics for chronic conditions with limited therapeutic options. "Piton Therapeutics, formerly known as Precidiag, is at the forefront of a revolution in the discovery and development of precision therapeutics for chronic and systemic diseases. Piton Therapeutics is a biotechnology firm that is involved in discovery and development of therapeutics for chronic and systemic diseases. Jan 23, 2025 ยท Unlike traditional microbiome companies, Piton focuses on targeted small- and large-molecule drugs with defined mechanisms of action, guided by its proprietary AI-based Drug Discovery platform. The company develops AI-enabled, precision small molecule drugs that target pathogenic pathways in the gut microbiome for the treatment of complex diseases. The company employs a proprietary platform to discern the gut microbiome’s role in the cause and Leadership Piton Therapeutics is led by a seasoned and mission-driven leadership team with a proven track record in biotech innovation, drug development, and company building. Use the PitchBook Platform to explore the full profile. 9 million in annual Piton Therapeutics | 1,113 followers on LinkedIn. Our executives bring together deep scientific expertise, strategic insight, and operational excellence to drive Piton’s vision forward. The discovery of strain-specific . Piton is the first therapeutic strategy to target a cause of UC. This orally dosed, gut-restricted, small molecule drug offers a new treatment paradigm for ~45% of UC patients – remission without compromising their immune system or unwanted side-effects. Several diseases are now being linked to disruptions of the human gut microbiome. Piton Therapeutics: Pioneering a New Approach to Microbiome-Inspired Drug Discovery At Piton Therapeutics, we are advancing small molecule therapeutics that originate from microbiome science but follow the precision and rigor of traditional pharmaceutical development. xchf l5jujo6 vq29 4bexjs c8dd yn k4e6yylb 5w6 441 morc